Denali Capital Extends Deadline on Longevity Biomedical Deal

Denali Capital Acquisition said $50,000 was deposited into its trust to extend the deal deadline by another month to April 11. The SPAC has a merger agreement with Longevity Biomedical, which is focused on advancing new technologies across therapeutics, health monitoring and solutions “to increase human health span.” 

Redemptions have removed most of the SPAC's trust, although Longevity Biomedical in August agreed to waive the deal's $30 million cash closing condition. Denali also has an $18 milion commitment with FutureTech Capital to support the transaction.

The deal was announced in January 2023. Read more.


Source: Denali Capital Extends Deadline on Longevity Biomedical Deal